Back to search

United Kingdom· GB-APID-9379911000001107

Pinetarsol 1.6% gel

A medicinal product containing tar, registered in United Kingdom by Ego Pharmaceuticals.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedPinetarsol 1.6% gelATC—REGISTER NO.GB-APID-9379911000001…PACKS LISTED1CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Tar
Manufacturer
Ego Pharmaceuticals
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    9314839003189

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tar in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tar products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bf35cf5d-56d3-4999-a649-64df23d9823a
GET /v1/drugs/bf35cf5d-56d3-4999-a649-64df23d9823a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "9379911000001107",
  "desc": "Pinetarsol 1.6% gel (Ego Pharmaceuticals)",
  "form": "Cutaneous gel",
  "vpid": "9382811000001101",
  "source": "dmd",
  "vtm_id": "42777111000001106",
  "strength": "16 mg",
  "substance": "Tar",
  "ingredient": "Tar",
  "supplier_code": "9383311000001100"
}

See everything about tar.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.